Terminal · Institutions

Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.

Artia Global Partners LP 13F Holdings -- Portfolio & Top Positions (2026-06-30)

Artia Global Partners LP (CIK 1937964) reported $541.9M across 47 reported positions in its SEC 13F filing for 2026-06-30. Largest positions: ABVX ($68.8M, 12.70%), INSM ($62.8M, 11.59%), TRVI ($41.2M, 7.61%), BTSG ($36.1M, 6.66%), RVMD ($34.7M, 6.41%). Source: SEC Form 13F.

RankTickerCompanyValue% PortfolioSharesAction
1ABVXABIVAX SA$68.8M12.70%516,447Trimmed
2INSMINSMED INC$62.8M11.59%589,052Trimmed
3TRVITREVI THERAPEUTICS INC$41.2M7.61%2.2MAdded
4BTSGBRIGHTSPRING HEALTH SVCS INC$36.1M6.66%517,315Added
5RVMDREVOLUTION MEDICINES INC$34.7M6.41%185,390Added
6ARGXARGENX SE$27.6M5.09%29,739Hold
7ALKSALKERMES PLC$23.5M4.34%448,964New
8TVTXTRAVERE THERAPEUTICS INC$19.3M3.55%339,033Added
9AZNASTRAZENECA PLC$18.7M3.44%98,376Added
10NAMSNEWAMSTERDAM PHARMA COMPANY$17.1M3.15%503,936Hold
11DNTHDIANTHUS THERAPEUTICS INC$15.9M2.93%162,990Hold
12XBISPDR SERIES TRUST$15.8M2.92%100,000New
13DGXQUEST DIAGNOSTICS INC$13.8M2.55%65,122Added
14IONSIONIS PHARMACEUTICALS INC$11.4M2.11%144,376Hold
15EYPTEYEPOINT INC$11.0M2.02%767,098Hold
16ALMSALUMIS INC$7.8M1.45%278,546Trimmed
17VKTXVIKING THERAPEUTICS INC$7.1M1.30%180,731Hold
18CELCCELCUITY INC$6.2M1.15%59,316Added
19CYTKCYTOKINETICS INC$6.0M1.11%70,700Added
20MRKMERCK & CO INC$6.0M1.11%46,700Hold
21RAPPRAPPORT THERAPEUTICS INC$5.8M1.07%138,508Hold
22JNJJOHNSON & JOHNSON$5.7M1.06%22,600Hold
23GHGUARDANT HEALTH INC$5.7M1.05%38,100New
24ABSIABSCI CORPORATION$5.4M0.99%464,444New
25SRRKSCHOLAR ROCK HLDG CORP$5.3M0.98%96,285Hold

Source: SEC Form 13F filings · as of 2026-06-30